Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Distler

Showing results (601-610 of 622) with videos related to

Pageof 63
Sort By:
Annals of the Rheumatic Diseases|June 17, 2010
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) databaseAnthony J Tyndall, Bettina Bannert, Madelon Vonk, et al.
Thorax|December 26, 2013
Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trialsLesley Ann Saketkoo, Shikha Mittoo, Dörte Huscher, et al.
Annals of the Rheumatic Diseases|October 5, 2013
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiativeFrank van den Hoogen, Dinesh Khanna, Jaap Fransen, et al.
Arthritis and Rheumatism|October 15, 2013
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiativeFrank van den Hoogen, Dinesh Khanna, Jaap Fransen, et al.
Rheumatology (Oxford, England)|September 29, 2022
Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive diseaseDavid Roofeh, Kevin K Brown, Ella A Kazerooni, et al.
Rheumatology (Oxford, England)|March 24, 2023
Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period-a cross-sequential study based on COVAD surveysKshitij Jagtap, R Naveen, Jessica Day, et al.
Rheumatology (Oxford, England)|March 2, 2024
Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD studyLeonardo Santos Hoff, Naveen Ravichandran, Parikshit Sen, et al.
Rheumatology (Oxford, England)|April 2, 2023
Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD studySasha Saadia Ali, Naveen R, Parikshit Sen, et al.
Rheumatology International|June 23, 2023
Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD studyBohdana Doskaliuk, Naveen Ravichandran, Parikshit Sen, et al.
International Journal of Rheumatic Diseases|November 16, 2023
Flares of autoimmune rheumatic disease following COVID-19 infection: Observations from the COVAD studyNimrat Kaur Sandhu, Naveen Ravichandraan, Arvind Nune, et al.
Pageof 63

Showing results (601-610 of 622) with videos related to

Sort By:
Pageof 63
Annals of the Rheumatic Diseases|June 17, 2010
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) databaseAnthony J Tyndall, Bettina Bannert, Madelon Vonk, et al.
Thorax|December 26, 2013
Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trialsLesley Ann Saketkoo, Shikha Mittoo, Dörte Huscher, et al.
Annals of the Rheumatic Diseases|October 5, 2013
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiativeFrank van den Hoogen, Dinesh Khanna, Jaap Fransen, et al.
Arthritis and Rheumatism|October 15, 2013
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiativeFrank van den Hoogen, Dinesh Khanna, Jaap Fransen, et al.
Rheumatology (Oxford, England)|September 29, 2022
Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive diseaseDavid Roofeh, Kevin K Brown, Ella A Kazerooni, et al.
Rheumatology (Oxford, England)|March 24, 2023
Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period-a cross-sequential study based on COVAD surveysKshitij Jagtap, R Naveen, Jessica Day, et al.
Rheumatology (Oxford, England)|March 2, 2024
Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD studyLeonardo Santos Hoff, Naveen Ravichandran, Parikshit Sen, et al.
Rheumatology (Oxford, England)|April 2, 2023
Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD studySasha Saadia Ali, Naveen R, Parikshit Sen, et al.
Rheumatology International|June 23, 2023
Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD studyBohdana Doskaliuk, Naveen Ravichandran, Parikshit Sen, et al.
International Journal of Rheumatic Diseases|November 16, 2023
Flares of autoimmune rheumatic disease following COVID-19 infection: Observations from the COVAD studyNimrat Kaur Sandhu, Naveen Ravichandraan, Arvind Nune, et al.
Pageof 63